The 27 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 32.00, with a high estimate of 45.00 and a low estimate of 24.00. The median estimate represents a +15.98% increase from the last price of 27.59.
The current consensus among 31 polled investment analysts is to Hold stock in Teladoc Health Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.23
Reporting Date Feb 21
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.